vs
Side-by-side financial comparison of AGENUS INC (AGEN) and CAMDEN NATIONAL CORP (CAC). Click either name above to swap in a different company.
CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $34.2M, roughly 1.9× AGENUS INC). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs -31.0%, a 65.0% gap on every dollar of revenue. Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs 10.5%).
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
AGEN vs CAC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $34.2M | $64.3M |
| Net Profit | $-10.6M | $21.9M |
| Gross Margin | — | — |
| Operating Margin | 42.1% | — |
| Net Margin | -31.0% | 34.0% |
| Revenue YoY | 27.5% | — |
| Net Profit YoY | 77.3% | — |
| EPS (diluted) | $0.09 | $1.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $64.3M | ||
| Q4 25 | $34.2M | $68.1M | ||
| Q3 25 | $30.2M | $65.4M | ||
| Q2 25 | $25.7M | $62.3M | ||
| Q1 25 | $24.1M | $60.1M | ||
| Q4 24 | $26.8M | $47.6M | ||
| Q3 24 | $25.1M | $45.0M | ||
| Q2 24 | $23.5M | $42.8M |
| Q1 26 | — | $21.9M | ||
| Q4 25 | $-10.6M | $22.6M | ||
| Q3 25 | $63.9M | $21.2M | ||
| Q2 25 | $-30.0M | $14.1M | ||
| Q1 25 | $-26.4M | $7.3M | ||
| Q4 24 | $-46.8M | $14.7M | ||
| Q3 24 | $-67.2M | $13.1M | ||
| Q2 24 | $-54.8M | $12.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 97.9% | — | ||
| Q2 25 | 99.1% | — | ||
| Q1 25 | 99.4% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 99.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 42.1% | 41.5% | ||
| Q3 25 | -15.0% | 40.5% | ||
| Q2 25 | -65.0% | 28.5% | ||
| Q1 25 | -55.3% | 10.3% | ||
| Q4 24 | -96.5% | 38.7% | ||
| Q3 24 | -125.5% | 35.2% | ||
| Q2 24 | -128.4% | 34.7% |
| Q1 26 | — | 34.0% | ||
| Q4 25 | -31.0% | 33.1% | ||
| Q3 25 | 211.4% | 32.4% | ||
| Q2 25 | -116.8% | 22.6% | ||
| Q1 25 | -109.6% | 12.2% | ||
| Q4 24 | -174.4% | 30.8% | ||
| Q3 24 | -267.7% | 29.1% | ||
| Q2 24 | -233.1% | 28.0% |
| Q1 26 | — | $1.29 | ||
| Q4 25 | $0.09 | $1.33 | ||
| Q3 25 | $1.94 | $1.25 | ||
| Q2 25 | $-1.00 | $0.83 | ||
| Q1 25 | $-1.03 | $0.43 | ||
| Q4 24 | $-1.95 | $1.00 | ||
| Q3 24 | $-3.08 | $0.90 | ||
| Q2 24 | $-2.52 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.0M | — |
| Total DebtLower is stronger | $44.7M | $514.4M |
| Stockholders' EquityBook value | $-271.1M | $710.0M |
| Total Assets | $226.8M | $7.0B |
| Debt / EquityLower = less leverage | — | 0.72× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.0M | — | ||
| Q3 25 | $3.5M | — | ||
| Q2 25 | $9.5M | — | ||
| Q1 25 | $18.5M | — | ||
| Q4 24 | $40.4M | — | ||
| Q3 24 | $44.8M | — | ||
| Q2 24 | $93.7M | — |
| Q1 26 | — | $514.4M | ||
| Q4 25 | $44.7M | — | ||
| Q3 25 | $34.2M | — | ||
| Q2 25 | $33.9M | — | ||
| Q1 25 | $33.6M | — | ||
| Q4 24 | $33.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $710.0M | ||
| Q4 25 | $-271.1M | $696.6M | ||
| Q3 25 | $-274.1M | $676.4M | ||
| Q2 25 | $-354.6M | $652.1M | ||
| Q1 25 | $-341.8M | $640.1M | ||
| Q4 24 | $-326.4M | $531.2M | ||
| Q3 24 | $-292.3M | $529.9M | ||
| Q2 24 | $-241.3M | $508.3M |
| Q1 26 | — | $7.0B | ||
| Q4 25 | $226.8M | $7.0B | ||
| Q3 25 | $233.9M | $7.0B | ||
| Q2 25 | $185.2M | $6.9B | ||
| Q1 25 | $200.2M | $7.0B | ||
| Q4 24 | $226.3M | $5.8B | ||
| Q3 24 | $238.5M | $5.7B | ||
| Q2 24 | $292.4M | $5.7B |
| Q1 26 | — | 0.72× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.6M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-16.6M | $63.9M | ||
| Q3 25 | $-14.7M | $36.1M | ||
| Q2 25 | $-20.2M | $6.0M | ||
| Q1 25 | $-25.6M | $1.0M | ||
| Q4 24 | $-28.7M | $60.9M | ||
| Q3 24 | $-53.3M | $-14.5M | ||
| Q2 24 | $-38.2M | $14.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $58.2M | ||
| Q3 25 | — | $35.4M | ||
| Q2 25 | $-20.2M | $4.5M | ||
| Q1 25 | $-25.6M | $-727.0K | ||
| Q4 24 | $-28.7M | $55.4M | ||
| Q3 24 | $-53.3M | $-16.2M | ||
| Q2 24 | $-38.6M | $13.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 85.5% | ||
| Q3 25 | — | 54.1% | ||
| Q2 25 | -78.7% | 7.3% | ||
| Q1 25 | -106.5% | -1.2% | ||
| Q4 24 | -107.0% | 116.4% | ||
| Q3 24 | -212.2% | -36.0% | ||
| Q2 24 | -164.4% | 30.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 8.4% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 2.4% | ||
| Q1 25 | 0.0% | 2.9% | ||
| Q4 24 | 0.3% | 11.7% | ||
| Q3 24 | 0.0% | 3.8% | ||
| Q2 24 | 2.0% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.83× | ||
| Q3 25 | -0.23× | 1.70× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.14× | ||
| Q4 24 | — | 4.15× | ||
| Q3 24 | — | -1.11× | ||
| Q2 24 | — | 1.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGEN
| Non Cash Royalty Revenue | $31.1M | 91% |
| Other | $3.2M | 9% |
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
